Section of Palliative Care, Department of Medicine, Beth Israel Deaconness Medical Center, Boston, MA, USA.
Department of Palliative, Rehabilitation and Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1414, Houston, TX, 77030, USA.
Support Care Cancer. 2021 Sep;29(9):4895-4898. doi: 10.1007/s00520-021-06183-z. Epub 2021 Apr 2.
Family/caregiver visitation provides critical support for patients confronting cancer and is associated with positive outcomes. However, the COVID-19 pandemic brought historic disruptions including widespread visitation restrictions. Here, we characterize in-depth the visitor policies of NCI-designated comprehensive cancer centers (CCCs) and analyze geographic/temporal patterns across CCCs.
The public-facing CCC websites, including archived webpages, were reviewed to abstract initial visitation policies and revisions, including end-of-life (EoL) exceptions and timing of visitation restrictions relative to regional lockdowns. Chi-squared and Fisher's exact tests were employed to analyze associations between geographic region, timing, and severity of restrictions.
Most CCCs (n=43, 86%) enacted visitation restrictions between March 15 and April 15, 2020. About half barred all visitors for COVID-negative inpatients (n=24, 48%) or outpatients (n=26, 52%). Most (n=36, 72%) prohibited visitors for patients with confirmed/suspected COVID-19. Most (n=40, 80%) published EoL exceptions but the specifics were highly variable. The median time from initial restrictions to government-mandated lockdowns was 1 day, with a wide range (25 days before to 26 days after). There was no association between timing of initial restrictions and geographic location (p=0.14) or severity of inpatient policies (p=1.0), even among centers in the same city. Outpatient policies published reactively (after lockdown) were more restrictive than those published proactively (p=0.04).
CCCs enacted strict but strikingly variable COVID-19 visitation restrictions, with important implications for patients/families seeking cancer care. A unified, evidence-based approach to visitation policies is needed to balance proven infection control measures with the needs of patients and families.
家属/护理人员探访为癌症患者提供了重要支持,并与积极的结果相关。然而,COVID-19 大流行带来了历史性的干扰,包括广泛的探访限制。在这里,我们详细描述了 NCI 指定的综合性癌症中心(CCC)的访客政策,并分析了 CCC 之间的地理/时间模式。
审查了 CCC 的面向公众的网站,包括存档网页,以提取初始访客政策和修订内容,包括临终(EoL)例外情况以及相对于区域封锁的访客限制时间。使用卡方检验和 Fisher 精确检验分析地理区域、时间和限制严重程度之间的关联。
大多数 CCC(n=43,86%)在 2020 年 3 月 15 日至 4 月 15 日期间实施了探访限制。大约一半的 CCC(n=24,48%)禁止 COVID-19 阴性住院患者或门诊患者(n=26,52%)的所有访客。大多数 CCC(n=36,72%)禁止有确诊/疑似 COVID-19 的患者的访客。大多数 CCC(n=40,80%)发布了 EoL 例外情况,但具体情况差异很大。从最初的限制到政府强制封锁的中位数时间为 1 天,范围很广(25 天前至 26 天后)。初始限制的时间与地理位置(p=0.14)或住院政策的严重程度(p=1.0)之间没有关联,即使是在同一城市的中心也是如此。在封锁后发布的门诊政策比在封锁前发布的政策更具限制性(p=0.04)。
CCC 实施了严格但差异很大的 COVID-19 探访限制,这对寻求癌症治疗的患者/家庭有重要影响。需要采用统一的、基于证据的访客政策方法,平衡经证实的感染控制措施与患者和家庭的需求。